CX Institutional Lowers Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• CX Institutional reduced its HCA Healthcare stake by 69% in the third quarter, selling 15,257 shares and retaining 6,847 shares valued at approximately $2.92 million. Institutional investors collectively own 62.73% of the company.
• Analysts remain broadly positive, with 15 Buy ratings, eight Holds, and one Sell rating. HCA has a consensus rating of “Moderate Buy” and an average price target of $463.70.
• HCA reported quarterly revenue of $20.23 billion and adjusted earnings of $7.59 per share, exceeding analyst estimates; revenue increased 8.7% year over year. The company also pays a quarterly dividend of $0.78 per share, yielding about 0.7% annually.

CX Institutional cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 69.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,847 shares of the company's stock after selling 15,257 shares during the quarter. CX Institutional's holdings in HCA Healthcare were worth $2,922,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. MidFirst Bank bought a new stake in shares of HCA Healthcare in the 2nd quarter worth about $28,000. Clearstead Trust LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $29,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the 1st quarter valued at $33,000. MCF Advisors LLC increased its position in HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company's stock valued at $34,000 after acquiring an additional 49 shares during the last quarter. Finally, Delos Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth about $35,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on HCA shares. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a research report on Friday. BMO Capital Markets started coverage on HCA Healthcare in a report on Tuesday, September 22nd. They issued an "outperform" rating and a $495.00 price target on the stock. UBS Group cut their price objective on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a report on Tuesday, July 14th. Finally, Truist Financial decreased their price target on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $463.70.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $427.09 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a 50 day moving average price of $417.13 and a 200 day moving average price of $422.29. The company has a market capitalization of $92.46 billion, a PE ratio of 14.30, a price-to-earnings-growth ratio of 1.43 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the prior year, the company earned $6.84 EPS. HCA Healthcare's revenue was up 8.7% on a year-over-year basis. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were given a dividend of $0.78 per share. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.